Showing 611-620 of 5621 results for "".
Double Whammy
https://modernod.com/topics/patient-care/double-whammy/38878/Optic neuritis caused by multiple sclerosis is a diagnosis you don’t want to miss.Vision Correction Guidelines for Patients Approaching Presbyopia
https://modernod.com/topics/contact-lenses/vision-correction-guidelines-for-patients-approaching-presbyopia/38781/Boost your multifocal contact lens fitting rates with effective patient engagement.Maximize the Business of Contact Lenses
https://modernod.com/topics/contact-lenses/maximize-the-business-of-contact-lenses/38599/Strategies for making the most out of this aspect of your practice.A Double-Header: Dry Eye and Filamentary Keratitis
https://modernod.com/mod-issues/2022-mar/a-double-header-dry-eye-and-filamentary-keratitis/38396/This case shows how dehydrated human amniotic membrane can be an effective treatment option for patients with both conditions.A Primer on Herpes Simplex Keratitis
https://modernod.com/topics/business/a-primer-on-herpes-simplex-keratitis/37939/Are you ready to manage patients with this common disease?Rethinking Outflow
https://modernod.com/topics/glaucoma/rethinking-outflow/38321/A new glaucoma management tool measures what eye care providers strive to improve.What the Cell Is That?
https://modernod.com/topics/corneaanterior-segment/what-the-cell-is-that/38877/A case of bilateral anterior uveitis in a 41-year-old female patient.New Treatments for Diabetic Eye Disease
https://modernod.com/topics/retina/new-treatments-for-diabetic-eye-disease/38894/A rundown of the latest therapy options in clinical trials—and a few in earlier developmental stages.The Future of Eye Care for Children
https://modernod.com/topics/health-policy/the-future-of-eye-care-for-children/38825/Part one of this multi-part series analyzes proposed legislation to support early eye care intervention in children.Achieving Durable Outcomes in Treatment-Naïve nAMD
https://modernod.com/specialty/retina/Achieving-Durable-Outcomes-in-treatment-naive-nAMD-2506/33189/Drs. Garg and Wykoff discuss a treatment-naïve patient with neovascular age-related macular degeneration and the impact of second-generation agents.